This is a preview of subscription content, log in via an institution to check access.
Reference
Komatsu M, et al. Improvement of crizotinib-resistant leptomeningeal carcinomatosis by switching to alectinib in a case of non-small cell lung cancer anaplastic lymphoma kinase (ALK) translocation. Haigan / Japanese Journal of Lung Cancer 55: 223-227, No. 4, 2015. Available from: URL: http://doi.org/10.2482/haigan.55.223 - Japan
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1574, 19 (2015). https://doi.org/10.1007/s40278-015-1475-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-1475-z